NORTHBROOK, Ill., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William Moffitt, Nanosphere's President and Chief Executive Officer, will present at the following investor conferences in New York City:
- Lazard 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 8:00 a.m. ET
- Stephens Fall Investment Conference on Wednesday, November 14, 2012 at 4:00 p.m. ET
Interested investors can access a live webcast of the Lazard Capital Markets presentation by going to the Investor Relations tab on the Nanosphere website: www.nanosphere.us. A replay of the webcast will be made available on the Company's website for 90 days.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344